Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
23.75
-0.45 (-1.86%)
At close: Nov 17, 2026
SHA:688443 Market Cap
SHA:688443 has a market cap or net worth of 8.71 billion as of November 16, 2026. It is the 8,350th most valuable company in the world and the 1,690th biggest in China. Its market cap has decreased by 19.38% in one year.
Market Cap
8.71B
Enterprise Value
7.77B
Revenue
800.98M
Global Rank
Country Rank
#1,690 China
PE Ratio
n/a
ChartMarket Cap Chart
Since June 20, 2023, SHA:688443's market cap has decreased from 12.47B to 8.71B, a decrease of -30.19%. That is a compound annual growth rate of -9.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 8.71B | -12.81% |
| Dec 31, 2025 | 9.99B | 8.57% |
| Dec 31, 2024 | 9.20B | -37.20% |
| Dec 29, 2023 | 14.65B | 17.43% |
| Jun 20, 2023 | 12.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tibet Cheezheng Tibetan Medicine | 10.50B |
| Shanghai Medicilon | 10.16B |
| Novoprotein Scientific | 9.40B |
| Shanghai OPM Biosciences | 9.23B |
| Staidson (Beijing) BioPharmaceuticals | 9.22B |
| Mabwell (Shanghai) Bioscience | 8.80B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 8.74B |
| Hualan Biological Vaccine | 8.73B |